 Home > Biochemistry News > Biotechnology News > US$2.3 billion to help develop ready-to-use natural killer cell therapy Kite to reach a partnership

US$2.3 billion to help develop ready-to-use natural killer cell therapy Kite to reach a partnership

 Last Update: 2021-09-07
 Source: Internet
 Author: User

Tags

cell diffusion definition

cell free dna

Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

On the 17th, Kite, a subsidiary of Gilead Sciences, and Shoreline Biosciences announced the establishment of a strategic partnership to develop new cell therapies that span multiple targets for hematological malignancies

This collaboration will combine Shoreline's deep expertise in induced pluripotent stem cell (iPSC) differentiation and gene reprogramming, and Kite's extensive cell therapy development technology, commercialization and production capabilities to jointly develop a series of innovations for the treatment of hematological malignancies Allogeneic (allogeneic) candidate therapy

Shoreline is committed to using smart technology to develop ready-to-use, standardized targeted cell therapies through iPSC, and has established a pipeline of candidate drugs for NK cell/macrophage therapy for the treatment of cancer and other serious diseases

▲Shoreline's iPSC-based cell therapy platform (picture source: Shoreline's official website)

Dr.

Reference materials:

[1] Kite and Shoreline Biosciences Enter Into Strategic Partnership to Develop Novel Allogeneic Cell Therapies.

This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

Related Products

L-Ascorbate-2-Monophosphate Feed Grade

CAS No.: 109620-90-8

Feed Grade

Potassium Sorbate from reliable manufacturer

CAS No.: 590-00-1

Food Grade

Doxycycline Hydrochloride

CAS No.: 10592-13-9

Pharmaceutical Grade

Hot Tags

united states jobs(223)

jobs united states(236)

1 year treasury(277)

1 year subscription(296)

announcements today(81)

80 20 company(94)

united states logo(227)

single use technology(195)

healthy food name(42)

ups united states(221)

Hot Articles

The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.